Research & Development
Baxter, BioMerieux receive CE Mark for kidney test
The companies highlighted the results of a study that showed the test's area under the receiver operating characteristic curve was 0.82, demonstrating its ability to distinguish patients who will likely develop such kidney injuries from those who will not.
October 21, 2021
AACC releases guidance on kidney injury lab testing
One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient has an injured kidney using creatinine testing. This was recommended due to recent evidence that has linked the 2012 Kidney Disease Improving Global Outcomes guidelines for creatinine testing with high rates of false positives.
May 11, 2021
Baxter, BioMerieux make deal on kidney test
The Nephrocleartm CCL14 test is in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI). The agreement is part of a previously announced collaboration between the companies to improve identification and treatment of AKI.
September 15, 2020
Biopsies show COVID-19 kidney injury not caused by virus in tissue
Two teams, one led by Dr. Vanesa Bijol of Northwell Health in Manhattan and another by Dr. Purva Sharma of the Feinstein Institutes for Medical Research in Manhasset, NY, found that existing kidney disease can be triggered or worsened by COVID-19. But the biopsies did not show viral presence in kidney tissue.
July 20, 2020
Speedy coronavirus tests | Making the most of mass spectrometry | Blood test foresees kidney injury
Dear LabPulse Member,
February 3, 2020
Breakthrough blood test to predict kidney injury may be on the way
Soluble urokinase plasminogen activator receptor is a protein made in the bone marrow by immune cells. The study, which was funded by the National Institutes of Health and a range of other groups, evaluated suPAR levels retrospectively in 4,769 patients, including 3,827 undergoing coronary angiography, 250 undergoing cardiac surgery, and 692 who were otherwise critically ill.
January 29, 2020
Sphingotec launches penKid kidney function blood test
The test was developed for the company's Nexus IB10 POC platform, which screens whole blood samples and delivers results within 20 minutes, according to Sphingotec. The test measures the level of the proenkephalin biomarker; elevated levels on penKid signify kidney damage and the risk of developing acute kidney injury.
January 15, 2020
Sphingotec's POC penKid blood test flags kidney injury
The study evaluated the diagnostic in combination with serum creatinine and estimated glomerular filtration rate (eGFR), an established marker of kidney function. Elevated results on penKid considered with eGFR results correlated with outcomes, according to the Hennigsdorf, Germany-based company. High penKid plasma levels identified all ED patients with hidden acute injury and acute kidney injury at the time of admission and reflected worsening of kidney function, the company explained.
December 22, 2019
Momentum builds for tests that predict kidney damage
Pairing the renal angina index (RAI) and urinary neutrophil gelatinase-associated lipocalin (uNGAL) in children seen in intensive care gives a more accurate picture of risk for acute kidney injury, researchers concluded in a study presented on November 9 at the American Society of Nephrology Kidney Week annual meeting in Washington, DC.
November 12, 2019
Page 1 of 1